Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
SUMMARY Lysine acetylation regulates gene expression through modulating protein-protein interactions in chromatin. Chemical inhibition of acetyl-lysine binding bromodomains of the major chromatin regulators BET (bromodomain and extra-terminal domain) proteins, has been shown to effectively block cell proliferation in cancer and inflammation. However, whether selective inhibition of individual BET bromodomains has distinctive functional consequences, remains only partially understood. In this study, we show that selective chemical inhibition of the first bromodomain of BET proteins using our newly designed small molecule inhibitor, Olinone, accelerated the progression of mouse primary oligodendrocyte progenitors towards differentiation, while inhibition of both bromodomains of BET proteins hindered differentiation. This effect was target-specific, as it was not detected in cells treated with inactive analogues and independent of any effect on proliferation. Therefore, selective chemical modulation of individual bromodomains, rather than use of broad-based inhibitors may enhance regenerative strategies in disorders characterized by myelin loss such as aging and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · cited 4×
“…even as compared to the recently developed: MS436, a diazobenzene compound (Zhang et al., 2013), or BETspecific BrDi, MS417, which is a thienotriazolo-diazepine compound (Zhang et al., 2012b) and structurally related to (+)-JQ1 (Filippakopoulos et al., 2010) and I-BET (Nicodeme et al., 2010).”
BackgroundInfluentialRNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 2×
“, 2010), acute myeloid leukemia (Zuber et al., 2011), MLL-fusion leukemia (Dawson et al.”
BackgroundStructure and ligand of a histone acetyltransferase bromodomain
Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732 · cited 1×
“The evolutionarily conserved bromodomain (BrD) functions as the acetyl-lysine binding domain (Dhalluin et al., 1999) for acetylated histones and transcription factors, which is required for ordered gene transcription in chromatin (Sanchez and Zhou, 2009).”
BackgroundSelf-citationSuppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563 · cited 3×
“It is important to note that Olinone is the first reported bromodomain inhibitor (BrDi) with a superior selectivity between the two bromodomains of BET proteins, even as compared to the recently developed: MS436, a diazobenzene compound (Zhang et al., 2013), or BETspecific BrDi, MS417, which is a thienotriazolo-diazep…”
BackgroundHDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
Ye, F., Chen, Y., Hoang, T., Montgomery, R. L., Zhao, X.-H., Bu, H., Hu, T., Taketo, M. M., van Es, J. H., Clevers, H., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2333 · Cited by 559 · cited 1×
“In this lineage, the early progenitor stage is characterized by global protein lysine acetylation and decreased global histone acetylation, was previously identified as critical for the proper onset of oligodendrocyte differentiation (Shen et al., 2008; Wu et al., 2012; Ye et al., 2009).”
Background
Cited by
Bromodomains: a new target class for drug development
Cochran, A. G., Conery, A. R., & Sims, R. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0030-7 · Cited by 412
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
Faivre, E. J., McDaniel, K. F., Albert, D. H., Mantena, S. R., Plotnik, J. P., Wilcox, D., Zhang, L., Bui, M. H., Sheppard, G. S., Wang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-1930-8 · Cited by 408
Drug Discovery Targeting Bromodomain-Containing Protein 4
Liu, Z., Wang, P., Chen, H., Wold, E. A., Tian, B., Brasier, A. R., & Zhou, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01761 · Cited by 303
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis
Liu, M., Cao, S., He, L., Gao, J., Arab, J. P., Cui, H., Xuan, W., Gao, Y., Sehrawat, T. S., Hamdan, F. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24843-w · Cited by 120
Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development
Chen, J., Tang, P., Wang, Y., Wang, J., Yang, C., Li, Y., Yang, G., Wu, F., Zhang, J., & Ouyang, L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01835 · Cited by 62
Metadata
- Authors
- Gacias, M., Gerona-Navarro, G., Plotnikov, A. N., Zhang, G., Zeng, L., Kaur, J., Moy, G., Rusinova, E., Rodriguez, Y., Matikainen, B., Vincek, A., Joshua, J., Casaccia, P., & Zhou, M.-M.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 21
- Issue
- 7
- Pages
- 841-854
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W2091368230
- Cited by
- 155
- References
- 5
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression. https://app.cochat.ai/papers/10.1016/j.chembiol.2014.05.009
- The paper
- Gacias, M., Gerona-Navarro, G., Plotnikov, A. N., Zhang, G., Zeng, L., Kaur, J., Moy, G., Rusinova, E., Rodriguez, Y., Matikainen, B., Vincek, A., Joshua, J., Casaccia, P., & Zhou, M.-M. (2014). Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression. Chemistry & Biology. https://doi.org/10.1016/j.chembiol.2014.05.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.